← Research library

Impact of tetrapeptide pancragen on endocrine function of the pancreas in old monkeys

Animal research · 2014

What was studied
Old female rhesus monkeys; younger comparison animals
Main finding
Reports glucose-clearance and insulin/C-peptide changes after treatment, with some changes persisting after withdrawal.

Insulin/C-peptide peak timing · 5 and 15 minutes after glucose in baseline experiments

Reported findings and study design

Older female rhesus monkeys; Pancragen 50 micrograms/animal/day IM for ten days; glucose-tolerance measurements.

Population or model Old female rhesus monkeys; younger comparison animals

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Insulin/C-peptide peak timing5 and 15 minutes after glucose in baseline experiments
Persistence of reported pancreatic responsePartly maintained three weeks after treatment stopped
Treatment effect magnitudeNot numerically quantified in abstract

Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • Non-human primates; no human efficacy or safety conclusion follows.
  • Full methods, adverse-event reporting and independent replication remain to be appraised.

Source details

Journal publication

Europe PMC indexed citation and abstract checked. Full original paper not reviewed.

Sources checked

Citation

Animal / experimentalEnglish abstract

Goncharova ND, Ivanova LG, Oganian TÉ, Vengerin AA, Khavinson VKh. Impact of tetrapeptide pancragen on endocrine function of the pancreas in old monkeys Advances in gerontology = Uspekhi gerontologii 27(4):662-667. PMID 25946840

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards